The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors.

Mullally, William J; Greene, John; Jordan, Emmet J; Horgan, Anne M; O'Connor, Miriam; Calvert, Paula M

Mullally, William J; Greene, John; Jordan, Emmet J; Horgan, Anne M; O'Connor, Miriam; Calvert, Paula M.

Afiliação

Mullally WJ; Department of Medical Oncology, University Hospital Waterford, Dunmore Road, Waterford, X91 ER8E, Ireland. willmullally@gmail.com.
Greene J; Department of Medical Oncology, University Hospital Waterford, Dunmore Road, Waterford, X91 ER8E, Ireland.
Jordan EJ; Department of Medical Oncology, University Hospital Waterford, Dunmore Road, Waterford, X91 ER8E, Ireland.
Horgan AM; Department of Medical Oncology, University Hospital Waterford, Dunmore Road, Waterford, X91 ER8E, Ireland.
O'Connor M; Department of Medical Oncology, University Hospital Waterford, Dunmore Road, Waterford, X91 ER8E, Ireland.
Calvert PM; Department of Medical Oncology, University Hospital Waterford, Dunmore Road, Waterford, X91 ER8E, Ireland.

Ir J Med Sci ; 192(1): 83-87, 2023 Feb.

Article em En | MEDLINE | ID: mdl-35304710

Assuntos

Inibidores de Checkpoint Imunológico; Neutrófilos; Humanos; Adulto; Pessoa de Meia-Idade; Idoso; Idoso de 80 Anos ou mais; Prognóstico; Linfócitos; Biomarcadores; Estudos Retrospectivos

Palavras-chave

Checkpoint inhibitors; Derived neutrophil-to-lymphocyte ratio; Immunotherapy biomarkers; Neutrophil-to-lymphocyte ratio

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neutrófilos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google